$8.44
-3.54%
N/A-$0.31
헬스케어
생명공학
NASDAQ
활발히 거래 중
Prothena Corporation plc는 후기 단계 임상 생명공학 회사로, 단백질 조절 이상으로 인한 질환을 치료하기 위한 새로운 치료제의 발굴 및 개발에 집중합니다. 이 ...
C-레벨 임원
(0)C-레벨 임원은 회사의 재무 전략과 혁신을 이끄는 응집된 리더십 팀입니다.
주요 팀원
이 단계의 임원이 없습니다
Founder / CEO
1
C-Level
9
VP
0
Board
0
Director / Board
1
Other
0
Key Executives
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Gene G. Kinney | 사장, 최고경영자(CEO) & 이사 | USD 1,124,507 | — | 1969 | Active |
| Tran Nguyen | 최고재무책임자(CFO) | USD 916,334 | 1974 | Active | |
| Brandon S. Smith | 최고운영책임자(COO) | USD 826,819 | 1975 | Active | |
| Chad Swanson | 최고개발책임자(CDO) | USD 739,084 | — | — | Active |
| Wagner Zago | 최고과학책임자(CSO) | USD 735,660 | — | 1973 | Active |
| Michael J. Malecek | 최고법무책임자 & 기업 비서 | USD 588,250 | 1966 | Active | |
| Annie Evans Kingston | 최고전략책임자(CSO) | — | — | Active | |
| Karin L. Walker | 최고회계책임자 & 컨트롤러 | — | 1963 | Active | |
| Phillip Dolan | 수석 이사 & 탐색 연구 책임자 | — | — | — | Active |
| Mark C. Johnson | 투자자 관계 담당 부사장 | — | — | Active | |
| Michael J. Isaacs | 법무총괄 & 기업 비서 | — | — | Active |
Executive Compensation
(deduped by latest filing date per person-year)| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2025 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $692.97K | $0 | $961.80K | $3.81M | $415.78K | $15.75K | $5.90M |
| 2026-03-27 | 2025 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $540.71K | $0 | $893.10K | $1.09M | $270.36K | $15.75K | $2.81M |
| 2026-03-27 | 2025 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $600.39K | $0 | $652.65K | $1.09M | $300.19K | $15.75K | $2.66M |
| 2026-03-27 | 2025 | Chad J. Swanson, Ph.D | Chief Chief Dev. Officer | Other | $516.67K | $0 | $583.95K | $1.09M | $206.67K | $15.75K | $2.42M |
| 2026-03-27 | 2025 | Wagner M. Zago, Ph.D. | Chief Chief Scientific Officer | C-Level | $514.22K | $0 | $583.95K | $1.09M | $205.69K | $15.75K | $2.41M |
| 2026-03-27 | 2024 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $654.13K | $0 | $0 | $6.17M | $392.48K | $15.53K | $7.23M |
| 2026-03-27 | 2024 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $580.09K | $0 | $0 | $1.71M | $290.04K | $15.53K | $2.59M |
| 2026-03-27 | 2024 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $520.32K | $0 | $0 | $1.71M | $260.16K | $15.53K | $2.50M |
| 2025-03-28 | 2024 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $514.30K | $0 | $0 | $1.71M | $205.72K | $15.53K | $2.44M |
| 2026-03-27 | 2024 | Wagner M. Zago, Ph.D. | Chief Chief Scientific Officer | C-Level | $492.00K | $0 | $0 | $1.71M | $196.80K | $15.53K | $2.41M |
| 2026-03-27 | 2023 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $630.55K | $0 | $0 | $6.04M | $359.41K | $14.85K | $7.04M |
| 2026-03-27 | 2023 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $550.41K | $0 | $0 | $1.87M | $264.88K | $14.85K | $2.70M |
| 2024-03-29 | 2023 | Hideki Garren, M.D., Ph.D. | Chief Chief Medical Officer | C-Level | $535.94K | $0 | $0 | $1.87M | $257.92K | $14.85K | $2.68M |
| 2026-03-27 | 2023 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $501.56K | $0 | $0 | $1.87M | $241.38K | $14.85K | $2.63M |
| 2025-03-28 | 2023 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $495.76K | $0 | $0 | $1.87M | $190.87K | $14.85K | $2.57M |
| 2025-03-28 | 2022 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $600.52K | $0 | $0 | $5.71M | $414.36K | $15.25K | $6.74M |
| 2024-03-29 | 2022 | Hideki Garren, M.D., Ph.D. | Chief Chief Medical Officer | C-Level | $510.42K | $0 | $0 | $1.94M | $283.92K | $15.25K | $2.75M |
| 2025-03-28 | 2022 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $480.39K | $0 | $0 | $1.94M | $267.22K | $15.25K | $2.70M |
| 2025-03-28 | 2022 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $476.25K | $0 | $0 | $1.94M | $264.91K | $15.25K | $2.70M |
| 2025-03-28 | 2022 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $472.15K | $0 | $0 | $1.94M | $210.11K | $15.25K | $2.64M |
| 2024-03-29 | 2021 | Hideki Garren, M.D., Ph.D. | Chief Chief Medical Officer | C-Level | $364.04K | $50.00K | $0 | $4.32M | $290.94K | $14.50K | $5.04M |
| 2024-03-29 | 2021 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $573.25K | $0 | $0 | $3.90M | $429.94K | $14.50K | $4.92M |
| 2024-03-29 | 2021 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $420.67K | $0 | $0 | $2.11M | $213.18K | $14.50K | $2.76M |
| 2024-03-29 | 2021 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $458.57K | $0 | $0 | $1.31M | $272.28K | $14.50K | $2.06M |
| 2024-03-29 | 2021 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $450.71K | $0 | $0 | $873.75K | $214.09K | $14.50K | $1.55M |
| 2023-03-31 | 2020 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $554.29K | $0 | $0 | $2.53M | $332.57K | $14.25K | $3.43M |
| 2023-03-31 | 2020 | Brandon S. Smith | Chief Chief Operating Officer | C-Level | $333.33K | $100.00K | $0 | $1.84M | $133.33K | $14.25K | $2.42M |
| 2023-03-31 | 2020 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $443.42K | $0 | $0 | $884.26K | $221.71K | $14.25K | $1.56M |
| 2023-03-31 | 2020 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $435.81K | $0 | $0 | $589.50K | $174.33K | $14.25K | $1.21M |
| 2021-03-31 | 2020 | Michael J. Malecek | Chief Chief Legal Officer and Company Secretary | C-Level | $410.00K | $0 | $0 | $589.50K | $164.00K | $14.25K | $1.18M |
| 2022-03-31 | 2019 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $538.13K | $0 | $0 | $2.34M | $322.88K | $14.00K | $3.21M |
| 2021-03-31 | 2019 | Michael J. Malecek | Chief Chief Legal Officer and Company Secretary | C-Level | $207.69K | $125.00K | $0 | $1.79M | $160.00K | $8.40K | $2.29M |
| 2022-03-31 | 2019 | Tran B. Nguyen | Chief Chief Strategy Officer and Chief Chief Financial Officer | C-Level | $430.50K | $0 | $0 | $906.71K | $215.25K | $14.00K | $1.57M |
| 2022-03-31 | 2019 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $423.12K | $0 | $0 | $477.21K | $169.25K | $14.00K | $1.08M |
| 2020-03-25 | 2019 | Radhika Tripuraneni, M.D., M.P.H. | Chief Chief Development Officer | C-Level | $403.20K | $0 | $0 | $477.21K | $161.28K | $14.00K | $1.06M |
| 2021-03-31 | 2018 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $525.00K | $0 | $0 | $10.58M | $283.50K | $12.38K | $11.40M |
| 2021-03-31 | 2018 | Tran B. Nguyen | Chief Chief Operating Officer and Chief Chief Financial Officer | C-Level | $412.50K | $0 | $0 | $4.36M | $173.14K | $12.38K | $4.96M |
| 2021-03-31 | 2018 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $410.67K | $0 | $0 | $2.86M | $151.95K | $12.38K | $3.44M |
| 2019-03-28 | 2018 | A. W. Homan | Chief Chief Legal Officer and Company Secretary | C-Level | $366.38K | $0 | $0 | $2.86M | $135.56K | $12.38K | $3.38M |
| 2019-03-28 | 2018 | Wagner M. Zago, Ph.D. | Chief Chief Scientific Officer | C-Level | $340.45K | $0 | $0 | $2.86M | $125.97K | $12.38K | $3.34M |
| 2020-03-25 | 2017 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $520.83K | $0 | $0 | $4.30M | $312.50K | $13.50K | $5.15M |
| 2020-03-25 | 2017 | Tran B. Nguyen | Chief Chief Operating Officer and Chief Chief Financial Officer | C-Level | $399.17K | $0 | $0 | $2.69M | $159.67K | $13.50K | $3.26M |
| 2019-03-28 | 2017 | Wagner M. Zago, Ph.D. | Chief Chief Scientific Officer | C-Level | $310.21K | $0 | $0 | $1.38M | $113.19K | $13.50K | $1.82M |
| 2020-03-25 | 2017 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $400.00K | $0 | $0 | $0 | $160.00K | $13.50K | $573.50K |
| 2019-03-28 | 2016 | Gene G. Kinney, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $425.00K | $0 | $0 | $4.09M | $208.69K | $11.93K | $4.74M |
| 2019-03-28 | 2016 | Carol D. Karp | Chief Chief Regulatory Officer | C-Level | $19.74K | $0 | $0 | $3.56M | $0 | $304.74K | $3.88M |
| 2019-03-28 | 2016 | Tran B. Nguyen | Chief Chief Operating Officer and Chief Chief Financial Officer | C-Level | $366.70K | $0 | $0 | $1.47M | $154.01K | $11.93K | $2.01M |
| 2019-03-28 | 2016 | Wagner M. Zago, Ph.D. | Chief Chief Scientific Officer | C-Level | $246.77K | $0 | $0 | $475.98K | $75.88K | $11.93K | $810.56K |
Total Compensation Trend
Sum of disclosed compensation by year (USD million)
Key Roles Compensation Lines
Top founder/C-level executives over time (USD million)